We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Assertio and Lupin Sued for Alleged Anti-Competitive Behavior
Assertio and Lupin Sued for Alleged Anti-Competitive Behavior
A proposed class action lawsuit in a California federal court claims Assertio Therapeutics and Lupin entered into a pay-for-delay agreement over Assertio’s diabetes drug Glumetza (metformin).